Home
Knowledge Hub

Knowledge Hub

Featured content

Keep ahead of pharmaceutical demand

Beyond the Device: Key Takeaways from PDA PFS 2026

Download Noble’s Integrated Advantage Report

Device Differences Matter: Why Addressing Negative Transfer Is Critical to Biosimilar Success

01

Beyond the Device: Key Takeaways from PDA PFS 2026

Beyond the Device: Key Takeaways from PDA PFS 2026

The 2026 PDA Universe of Pre-Filled Syringes and Injection Devices Conference brought the drug delivery community together in Palm Springs around the theme, “Where Molecules Meet Devices: Advancing Patient-Centric Solutions.” Across the program, the intersection of drug delivery, device development, combination products, technology and user experience was front and center.

Download Noble’s Integrated Advantage Report

Download Noble’s Integrated Advantage Report

Download the report to discover how pharmaceutical organizations can move beyond fragmented execution and create a stronger foundation for launch success, patient confidence, and long-term therapy adherence.

Keep ahead of pharmaceutical demand

Device Differences Matter: Why Addressing Negative Transfer Is Critical to Biosimilar Success

As biosimilar and interchangeable biologic therapies continue to expand patient access to treatment, the industry has an opportunity to focus on more than affordability and availability. The patient experience must remain a priority, particularly as new delivery devices enter the market.

What an Entrepreneurial Mindset Means in Pharma and Medical Device Development

What an Entrepreneurial Mindset Means in Pharma and Medical Device Development

Innovation is a constant in pharma and medical device development. But what separates true industry leaders is not just innovation—it’s an entrepreneurial mindset.

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

As healthcare continues its shift toward home-based care and self-administration, ensuring patients can use complex drug delivery devices correctly has never been more important. To support this evolving landscape, Noble, an Aptar Pharma company, has been awarded a new U.S. patent for an artificial intelligence-enabled method that uses sound recognition technology to help determine whether a drug delivery or diagnostic device has been operated correctly.

Starting with Curiosity: The Journey of Noble’s First Scholar

Starting with Curiosity: The Journey of Noble’s First Scholar

On June 2, Noble welcomed its first-ever Noble Scholar, launching a new chapter in the company’s commitment to developing future talent.